Biodesix IncNASDAQ:BDSX
- LAST PRICE2.0050
- TODAY'S CHANGE (%)0.0750 (3.8860%)
- Bid / Lots2.0000/ 2
- Ask / Lots2.0100/ 1
- Open / Previous Close2.0000 / 1.9300
- Day Range
- 52 Week Range
- Volume54,518
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BDSX |
|---|---|---|
| 09:32 ET | 3103 | 2 |
| 09:33 ET | 209 | 1.9632 |
| 09:35 ET | 500 | 1.96 |
| 09:39 ET | 20000 | 2 |
| 09:44 ET | 10300 | 2.005 |
| 09:50 ET | 500 | 2.05 |
| 09:51 ET | 1200 | 2.0413 |
| 10:02 ET | 11237 | 2 |
| 10:04 ET | 700 | 2.07 |
| 10:13 ET | 1550 | 2.015 |
| 10:20 ET | 500 | 2.0189 |
| 10:22 ET | 1310 | 2.005 |
| 10:29 ET | 500 | 2.005 |
Jan 31, 2023
Insider Buy: Biodesix, from 1:14PM ET on Tuesday Jan 31, 2023 by MT Newswires
1:14PM ET on Tuesday Jan 31, 2023 by MT Newswires
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biodesix Inc | 138.4M | -1.2x | --- |
Streamline Health Solutions Inc | 128.6M | -11.7x | --- |
Talkspace Inc | 130.5M | -1.5x | --- |
BioNexus Gene Lab Corp | 173.7M | -1,562.5x | --- |
Mainz Biomed NV | 99.9M | -4.0x | --- |
Global Cord Blood Corp | 397.5M | 4.9x | +20.97% |
Company Information
Biodesix, Inc. is a United States-based company engaged in developing and commercializing blood-based diagnostic tests for oncology. The Company’s product Biodesix Lung Reflex integrates genomic and proteomic blood-based results to reveal both sides of lung cancer. Its GeneStrat test offers blood-based mutation results within 72 hours for patients with non-small cell lung cancer (NSCLC). Its VeriStrat testing provides blood-based predictive and prognostic proteomic information with (NSCLC) who test negative for estimated glomerular filtration rate (EGFR) mutations (EGFR wild-type) or whose EGFR mutation status is unknown.
Contact Information
- Headquarters
- Suite 100, 2970 Wilderness PlaceBOULDER, CO, United States 80301
- Phone
- 303-417-0500
- Fax
- 303-417-9700
Executives
- Independent Chairman of the Board
- John Patience
- President, Chief Executive Officer, Director
- Scott Hutton
- Chief Financial Officer, Treasurer, Secretary
- Robin Cowie
- Chief Accounting Officer
- Ryan Siurek
- Director
- Lawrence Kennedy
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $138.4M |
|---|---|
Revenue (TTM) | $35.8M |
Shares Outstanding | 71.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.73 |
Book Value | $0.64 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | 3.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -143.67% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
